Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012. [electronic resource]
Producer: 20190801Description: 991-999 p. digitalISSN:- 1527-7755
- Aged
- Aged, 80 and over
- Androstenes -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Benzimidazoles -- administration & dosage
- Biomarkers, Tumor
- DNA Repair
- Humans
- Male
- Middle Aged
- Molecular Targeted Therapy
- Neoplasm Metastasis
- Poly(ADP-ribose) Polymerase Inhibitors -- administration & dosage
- Prednisone -- administration & dosage
- Prostatic Neoplasms, Castration-Resistant -- drug therapy
- Proto-Oncogene Proteins c-ets -- genetics
- Receptors, Androgen -- metabolism
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.